Cardiogenic shock is a critical medical condition characterized by a sudden and severe decrease in the heart's ability to pump blood effectively, leading to insufficient oxygen delivery to vital organs. This condition typically arises from a massive heart attack, severe heart failure, or other cardiac events that compromise the heart's pumping function. As the heart's pumping capacity diminishes, blood pressure drops, and vital organs like the brain, kidneys, and lungs receive inadequate oxygen and nutrients. Common symptoms of cardiogenic shock include rapid breathing, cold and clammy skin, confusion, and a weak pulse. Immediate medical intervention is essential to address the underlying cause and restore blood flow. Treatment may involve medications to support heart function, mechanical support devices, or, in severe cases, emergency interventions such as angioplasty or coronary artery bypass surgery. Prompt recognition and intervention are crucial for improving the chances of survival and minimizing long-term complications associated with cardiogenic shock.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India